ArticleBiochemistry and biophysics reports2025
Combined effects of hyperbaric oxygen and ozone therapy on biochemical markers in ischemia-reperfusion injury: An experimental study.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to compare the effects of hyperbaric oxygen therapy (HBO) and ozone therapy (OT) on ischemia-reperfusion injury in Sprague-Dawley rat rectus abdominis muscle (RAM) flaps through the analysis of oxidative stress markers. Methods: This experimental study involved 36 adult Sprague-Dawley rats divided into five groups: HBO, OT, HBO + OT, Control, and Sham. Ischemia-reperfusion injury was induced in RAM flaps for 4 h. Levels of myeloperoxidase (MPO), superoxide dismutase (SOD), and malondialdehyde (MDA) were measured in serum samples on the 1st and 7th days using the ELISA method. Results: SOD levels increased significantly on the 7th day in the HBO + OT group (p = 0.044). MPO levels were significantly elevated in the Sham and Control groups by day 7 (p = 0.049, p = 0.025). MDA levels increased significantly in the Control, OT, and HBO groups on day 7 (p = 0.028). While HBO and OT reduced oxidative stress, the combined HBO + OT therapy appeared to elevate oxidative stress markers over time. Conclusion: HBO and OT therapies show individual efficacy in reducing oxidative stress during ischemia-reperfusion injury. While both therapies reduced oxidative damage, combining them might offer additional protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.